Medication regimen of patients with a pseudoaneurysm.
收藏数据链接：
官方服务：
资源简介：
Medication regimen of patients with a pseudoaneurysm.
应用场景：
创建时间：
2021-08-24
相关数据集
data_sheet_1.PDF
BackgroundLocal delivery of monocyte chemotactic protein-1 (MCP-1/CCL2) via our drug-eluting coil has been shown to promote intrasaccular aneurysm healing via an inflammatory pathway. ObjectiveIn this
NIAID Data Ecosystem100
Data: outcome of embolization of an endoleak type 2 after placement of an endoprosthesis for an infrarenal aorta aneurysm
Objective: The aim is to investigate the effect of transarterial (TA) and translumbar (TL) embolization of a type 2 endoleak (T2EL) after endovascular aneurysm repair (EVAR) of an infrarenal abd
DataCite Commons2025-06-01 更新80
Endovascular Treatment of a Noninfected Anastomotic Juxtarenal Aortic Aneurysm
An 82-year-old man underwent an endovascular procedure with a commercially available endovascular graft for an anastomotic juxtarenal abdominal aortic aneurysm. The anastomotic aneurysm, which showed
PubMed Central40
Supplementary Material for: Evaluating the Safety of Stent-Assisted Endovascular Treatment for Unruptured Cerebral Aneurysms in Older Adults: Emphasizing the Role of Antiplatelet Therapy
Introduction: This study aimed to compare the outcomes and safety in patients aged ≥75 years and those aged <75 years who underwent stent-assisted endovascular treatment for unruptured cerebral ane
DataCite Commons2024-10-10 更新90
Supplementary Material for: Metformin Inhibits Abdominal Aortic Aneurysm Formation through the Activation of the AMPK/mTOR Signaling Pathway
Background and Objective: Epidemiological evidence suggests that the antidiabetic drug metformin (MET) can also inhibit abdominal aortic aneurysm (AAA) formation. However, the underlying protective me
NIAID Data Ecosystem60
